Well, thanks to intrepid reporter, Greg Weston, of Sun Media, P’n’P has learned that
industry insiders say lobbyists had long been trying to get rid of Keen for reasons that had nothing to do with medicine. Their clients were companies that stand to make huge money from the next generation of Canadian nuclear power reactors called the Advanced Candu, or ACR-1000. Rightly or wrongly, it seems, the iron-fisted Keen was getting in the way.
Keen would not agree to conduct a special review of AECL’s new toy design. But, exit Keen and enter Binder and everything changed!
Almost immediately after Binder took over from Keen, the supposedly independent, quasi-judicial safety commission reversed itself and agreed to conduct a pre-project review of Atomic Energy’s new ACR-1000 reactor design.
Seven months later, the commission concluded its review, finding the new Candu complies with “regulatory requirements and meets the expectations for new nuclear power plants in Canada.”
It’s like, well, it’s like MAGIC! Or something, eh?
Thanks to BCer in Toronto for pointing me to the article!